phrykt

Labcorp Holdings Inc. (LH): who owns it and who trades it

As of Nov 16, 2026, LH insiders reported 22 open-market sales worth $11.7M and no purchases in the last 12 months, with 58% of the sale value made under pre-set 10b5-1 plans. The largest seller was Adam H Schechter (CEO), with $6.9M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Labcorp

From the latest filings

Overall: more selling than buying. Insiders and Congress mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns LH

1,043 funds and institutions reported LH shares worth $22.4B at the end of Q2 2026, about 98% of the company. The largest holder is BlackRock, Inc. with 8.0%.

Funds and institutions (13F) 98%Everyone else 2%

10 largest owners, by share of the company

BlackRock, Inc.8.0%
Vanguard Capital Management LLC6.5%
Victory Capital Management Inc5.9%
State Street Corp4.8%
Vanguard Portfolio Management LLC4.5%
Boston Partners3.7%
Allspring Global Investments Holdings, LLC2.7%
Geode Capital Management, LLC2.7%
Select Equity Group, L.P.2.4%
FMR LLC (Fidelity)2.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.6.57M8.02%$1.8B+2%
Vanguard Capital Management LLC5.36M6.54%$1.5B-0%
Victory Capital Management Inc4.84M5.90%$1.4B+5%
State Street Corp3.91M4.77%$1.1B+1%
Vanguard Portfolio Management LLC3.68M4.49%$1B-0%
Boston Partners3.05M3.72%$854M+29%
Allspring Global Investments Holdings, LLC2.24M2.73%$635M+0%
Geode Capital Management, LLC2.19M2.67%$610M+0%
Select Equity Group, L.P.1.98M2.42%$555M-9%
FMR LLC (Fidelity)1.90M2.32%$533M+48%
Morgan Stanley1.61M1.96%$451M+7%
Dimensional Fund Advisors LP1.37M1.67%$383M+3%
JPMorgan Chase & Co1.27M1.55%$355M–
Invesco Ltd.1.24M1.51%$347M-6%
Nordea Investment Management AB915,9391.12%$255M-12%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC887,4311.08%$248M-1%
Northern Trust Corp883,0761.08%$247M-11%
Wellington Management Group LLP855,5961.04%$240M-11%
American Century Companies Inc845,0231.03%$237M+4%
Bank of America Corp812,2700.99%$227M+12%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, LH insiders reported $0 of open-market purchases and $11.7M of sales. 58% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$11.7M
22 trades, 10 people
Sales under a 10b5-1 plan
58%
Share of sale value
Latest trade
Nov 10, 2026
Filed Nov 12, 2026

Purchases and sales by month

$3.2M$3.2MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 10, 2026Brian J CaveneyVice presidentSale2,000$372.04$744KForm 4
Nov 3, 2026Bryan T VaughnVice presidentSale plan306$353.70$108KForm 4
Oct 30, 2026Richelle P ParhamDirectorSale1,078$361.22$389KForm 4
Aug 17, 2026Kerrii B AndersonDirectorSale plan3,000$318.02$954KForm 4
Aug 11, 2026Adam H SchechterCEOSale plan4,669$320.37$1.5MForm 4
Aug 4, 2026Amy B. SummyVice presidentSale924$306.74$283KForm 4
Aug 3, 2026Peter J WilkinsonVice presidentSale1,338$309.23$414KForm 4
Aug 3, 2026Peter J WilkinsonVice presidentSale82$309.22$25.4KForm 4
Jul 2, 2026Kathryn W KyleVice presidentSale plan92$286.19$26.3KForm 4
Jul 2, 2026Bryan T VaughnVice presidentSale plan234$286.19$67KForm 4
Jun 8, 2026Kathryn W KyleVice presidentSale plan762$263.89$201KForm 4
May 11, 2026Adam H SchechterCEOSale plan5,903$254.50$1.5MForm 4
Mar 27, 2026Peter J WilkinsonVice presidentSale plan1,633$267.05$436KForm 4
Mar 27, 2026Jonathan C MeltzerVice presidentSale plan839$267.05$224KForm 4
Mar 3, 2026Adam H SchechterCEOSale8,705$279.96$2.4MForm 4
Feb 27, 2026der Vaart Sandra D vanVice presidentSale548$284.91$156KForm 4
Feb 24, 2026Brian J CaveneyVice presidentSale1,500$286.31$429KForm 4
Feb 19, 2026Peter J WilkinsonVice presidentSale plan666$277.94$185KForm 4
Feb 12, 2026Jonathan C MeltzerVice presidentSale plan87$290.42$25.3KForm 4
Feb 11, 2026Adam H SchechterCEOSale plan5,273$284.38$1.5MForm 4
Feb 10, 2026Jonathan C MeltzerVice presidentSale plan91$276.79$25.2KForm 4
Feb 9, 2026Jonathan C MeltzerVice presidentSale plan88$275.53$24.2KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Adam H SchechterPresident & CEO, Director–$6.9MAug 11, 2026
Brian J CaveneyEVP, Pres of ED, CMO & CSO–$1.2MNov 10, 2026
Peter J WilkinsonSVP, Chief Accounting Officer–$1.1MAug 3, 2026
Kerrii B AndersonDirector–$954KAug 17, 2026
Richelle P ParhamDirector–$389KOct 30, 2026
Jonathan C MeltzerEVP, Operations–$299KMar 27, 2026
Amy B. SummyEVP, Chief Marketing Officer–$283KAug 4, 2026
Kathryn W KyleEVP, Chief Legal Officer–$227KJul 2, 2026
Bryan T VaughnEVP and President, Diagnostics–$175KNov 3, 2026
der Vaart Sandra D vanEVP, Corporate Affairs–$156KFeb 27, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

LH short interest

Low short interest. 3.1% of LH shares are sold short: about 1 share in 32. Over the last 12 reports the number of shares short went down 24%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 2.54M LH shares were sold short, 3.1% of the shares outstanding, down 0.5% from the report before. At the average daily volume of 846,259 shares, buying them all back would take about 3.0 trading days (days to cover).

Shares short, % of all shares

3.13%May 15Oct 304.45%

Days to cover

3.0May 15Oct 306.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20262.54M3.13%-1%846,2593.0
Oct 15, 20262.56M3.15%-5%606,7674.2
Sep 30, 20262.68M3.31%+10%892,5073.0
Sep 15, 20262.45M3.02%+16%740,7503.3
Aug 31, 20262.10M2.59%+9%660,4103.2
Aug 14, 20261.94M2.39%-7%505,3283.8
Jul 31, 20262.09M2.55%-23%959,1982.2
Jul 15, 20262.72M3.32%-4%575,1654.7
Jun 30, 20262.83M3.45%-13%743,8633.8
Jun 15, 20263.26M3.98%-5%544,7986.0
May 29, 20263.43M4.18%+2%588,5205.8
May 15, 20263.37M4.11%+7%718,2504.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded LH

Since Nov 17, 2024, 4 members of Congress reported 14 purchases and 6 sales of LH. The latest was a sale by April McClain Delaney on Aug 25, 2026, reported Sep 9, 2026.

Purchases 14Sales 6

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Aug 25, 2026April McClain Delaney (D-MD)Sale$100K–$250KChildSep 9, 2026Report
Aug 7, 2026April McClain Delaney (D-MD)Partial sale$1K–$15KChildSep 9, 2026Report
Aug 6, 2026April McClain Delaney (D-MD)Partial sale$1K–$15KChildSep 9, 2026Report
Aug 5, 2026April McClain Delaney (D-MD)Partial sale$1K–$15KChildSep 9, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Feb 11, 2026April McClain Delaney (D-MD)Purchase$1K–$15KChildMar 10, 2026Report
Feb 4, 2026April McClain Delaney (D-MD)Purchase$1K–$15KChildMar 10, 2026Report
Jan 28, 2026April McClain Delaney (D-MD)Purchase$1K–$15KChildFeb 2, 2026Report
Nov 17, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildDec 8, 2025Report
Oct 31, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildNov 4, 2025Report
Oct 29, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildNov 4, 2025Report
May 15, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMay 31, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfMay 8, 2025Report
Mar 31, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfApr 7, 2025Report
Feb 28, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildMar 20, 2025Report
Feb 27, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildMar 20, 2025Report
Feb 25, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMar 27, 2025Report
Feb 17, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildMar 20, 2025Report
Feb 8, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildMar 20, 2025Report
Feb 5, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildMar 20, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Labcorp company events

Labcorp filed 27 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026AnnouncementShared information with investors. Filing
  2. Oct 28, 2026ResultsReleased financial results. Filing
  3. Oct 21, 2026AnnouncementShared information with investors. Filing
  4. Sep 30, 2026AnnouncementShared information with investors. Filing
  5. Sep 22, 2026AnnouncementShared information with investors. Filing
  6. Sep 10, 2026AnnouncementShared information with investors. Filing
  7. Aug 28, 2026AnnouncementShared information with investors. Filing
  8. Aug 17, 2026AnnouncementShared information with investors. Filing
  9. Aug 14, 2026LeadershipMegan D. Bailey notified Labcorp Holdings Inc. of her decision to resign as Executive Vice President and President, Central Laboratories and International of the Company, effective September 4, 2026. Filing
  10. Jul 30, 2026ResultsReleased financial results. Filing
  11. Jul 10, 2026AnnouncementShared information with investors. Filing
  12. Jun 30, 2026AnnouncementShared information with investors. Filing
  13. May 27, 2026AnnouncementShared information with investors. Filing
  14. May 26, 2026VoteReported shareholder vote results. Filing
  15. Apr 30, 2026ResultsReleased financial results. Filing
  16. Apr 9, 2026AnnouncementShared information with investors. Filing
  17. Mar 31, 2026AnnouncementShared information with investors. Filing
  18. Mar 20, 2026AgreementLabcorp Holdings Inc., as parent guarantor, and Laboratory Corporation of America Holdings, as borrower, entered into a Term Loan Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, Wells Fargo Securities, LLC, as joint lead arranger and sole bookrunner, PNC… Filing
  19. Feb 17, 2026ResultsReleased financial results. Filing
  20. Feb 9, 2026LeadershipLabcorp Holdings Inc. today announced that on February 6, 2026, the Company’s Board of Directors appointed John H. Sampson, M.D., Ph.D., as a member of the Board, effective February 9, 2026. Filing
  21. Jan 29, 2026AgreementLabcorp Holdings Inc. amended its receivables purchase agreement (as amended, the “Receivables Purchase Agreement”) by entering into the Second Amendment to the Receivables Purchase Agreement, among Labcorp Receivables LLC, Laboratory Corporation of America Holdings, PNC Bank, National Association… Filing
  22. Jan 15, 2026AnnouncementShared information with investors. Filing
  23. Jan 14, 2026AnnouncementShared information with investors. Filing
  24. Dec 30, 2025AnnouncementShared information with investors. Filing
  25. Dec 15, 2025LeadershipMark Schroeder, the Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer of Labcorp Holdings Inc., notified the Company of his intention to retire, effective on April 1, 2026. Filing
  26. Dec 10, 2025LeadershipDr. D. Gary Gilliland notified the Board of Directors of Labcorp Holdings Inc. of his decision to retire from the Board, effective December 31, 2025. Filing
  27. Nov 24, 2025LeadershipLabcorp Holdings Inc. today announced that on November 20, 2025, the Company’s Board of Directors appointed Victor Bulto as a member of the Board, effective December 1, 2025. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Labcorp financials

Famous investors that hold LH

5 of the 50 well-known investors we track reported holding LH in their latest 13F filing. The largest position is Ken Griffin's, worth $81.8M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026265,420$81.8M0.0%+650%
Paul Tudor Jones · Tudor Investment CorpQ3 202674,626$23M0.1%New
Israel Englander · Millennium ManagementQ3 202659,429$18.3M0.0%-74%
Ray Dalio · Bridgewater AssociatesQ3 20262,654$818K0.0%-5%
Ken Fisher · Fisher Asset ManagementQ3 20261,556$480K0.0%+20%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Labcorp Holdings Inc. (LH) stock

Who owns the most LH stock?

The largest reported owner of Labcorp Holdings Inc. (LH) is BlackRock, Inc., with 8.0% of the company. In total, 1,043 funds and institutions reported holding LH at the end of Q2 2026, together about 98% of the shares. See the largest owners.

Are LH insiders buying or selling?

In the last 12 months, LH insiders reported no open-market purchases and 22 sales worth $11.7M. The latest trade was on Nov 10, 2026. See every trade.

What is the short interest in LH?

As of Oct 30, 2026, 2.54M LH shares were sold short, 3.1% of the shares outstanding, down 0.5% from the report before. At the average daily volume of 846,259 shares, buying them all back would take about 3.0 trading days (days to cover). See the history.

Have members of Congress traded LH?

Yes. 4 members of Congress reported 14 purchases and 6 sales of LH since Nov 17, 2024. The latest was reported on Sep 9, 2026. See the trades.

Which famous investors hold LH?

5 of the 50 well-known investors we track reported LH in their latest 13F filing, including Ken Griffin, Paul Tudor Jones, Israel Englander. The largest position is worth $81.8M. See all holders.

Executive pay

Labcorp's chief executive was paid a total of $18.3M for the year ended Dec 31, 2025, down 5% from $19.3M the year before. In the last 12 months, Labcorp's executives and directors bought no stock on the open market and sold $11.7M.

Chief executive, total pay$18.3MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$30.1MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$4.2MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.